Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center

Core Viewpoint - The agreement between CFFM and Pulsenmore marks a significant advancement in prenatal care, enabling remote monitoring through home ultrasound services, which enhances patient access and reduces unnecessary visits to diagnostic centers [1][5]. Company Overview - Pulsenmore is focused on transforming maternal health with home-use ultrasound technology that connects mothers and healthcare providers remotely, aiming to improve access and continuity of prenatal care [6]. - CFFM is a prenatal diagnostic center in California that specializes in high-risk pregnancies, managing approximately 1,500 pregnancies annually across two locations in the Los Angeles area [3]. Technological Innovation - Pulsenmore's ultrasound system is designed to empower expectant mothers by providing safe, guided access to ultrasound imaging from home or work, while maintaining close clinician involvement throughout the process [4]. - The collaboration with CFFM will facilitate a remote pregnancy monitoring model that prioritizes patient needs, demonstrating the potential of home-based ultrasound as a routine part of medical care [6]. Market Potential - The agreement with CFFM represents Pulsenmore's first commercial venture in the United States, following recent FDA clearance, and is seen as a crucial step in the company's strategic plan to tap into the U.S. market, which holds significant clinical and business opportunities [5].